دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
30 years of JEADV – 30 years of progress in Dermatology and Venereology
J. Ring
doi : 10.1111/jdv.17670
Volume 35, Issue 11 p. 2116-2117
Thirty years of new entities in inflammatory dermatology and dermatopathology
F. Rongioletti
doi : 10.1111/jdv.17653
Volume 35, Issue 11 p. 2121-2122
The changing landscape of managing hair loss: a 30-year perspective
L. Rudnicka
doi : 10.1111/jdv.17651
Volume 35, Issue 11 p. 2123-2124
Ambassadors in Dermatology and Venereology: an interview with Doctor Hans W. Rothenborg
Hans W. Rothenborg
doi : 10.1111/jdv.17661
Volume 35, Issue 11 p. 2125-2127
Treatment of keloids and hypertrophic scars. Position statement of the Brazilian expert group GREMCIQ
G.V. Oliveira,L.D. Metsavaht,B.V Kadunc,S.K.K. Jedwab,M.S. Bressan,H.O. Stolf,R.G. Castro,S.M.F.M.C. Bezerra,D.A. Calil,F.A.Z. Addor,J.C.S. Fraga,C.M.S. Reis,E. Reis-Filho,M.R. Silva,M. Ramos-e-Silva,D.M. Hexsel
doi : 10.1111/jdv.17484
Volume 35, Issue 11 p. 2128-2142
Keloids (K) and hypertrophic scars (HS) are abnormal responses to wound healing that occur as the result of dermal inflammation. Despite the advances on their treatment, many patients still suffer from the negative effects of excessive scarring; its approach is impaired by the lack of objective data on different treatments and the large genetic variability among patients and the difficulties in producing multicentre studies. Their incidence among the Brazilian population is high, as the result of an admixture of Amerindians, Europeans and Africans ancestral roots. With the aim of producing multicentre studies on K and HS, a panel of senior Brazilian dermatologists focused on their treatment was invited to contribute with the K and HS Treatment Brazilian Guidelines. In the first part of this study, different treatment modalities for keloids and HS are fully reviewed by the panel. The second part of the study presents a consensus recommendation of treatment for different types of lesions. More than a literature review, this article aims to show the pitfalls and pearls of each therapeutic option, as well as a therapeutic approach by the Panel of Experts on keloids and Scars on a highly mixed population, providing simple guidelines.
Position statement on the role of nurses in therapeutic patient education in atopic dermatitis
K. Thormann,H. Aubert,S. Barbarot,A. Britsch-Yilmaz,P. Chernyshov,M. Deleuran,M. El-Hachem,J. de Groot,A. Heratizadeh,F. Raymakers,J.F. Stalder,A. Wollenberg,D. Simon
doi : 10.1111/jdv.17487
Volume 35, Issue 11 p. 2143-2148
In chronic skin diseases such as atopic dermatitis (AD), therapeutic failure due to poor patient adherence to treatment is commonly reported. Therapeutic patient education (TPE) is an approach to improve self-management and adherence. Several studies demonstrated that TPE programmes have positive effects on disease management resulting in decreased disease severity and improved quality of life in AD patients. Various healthcare professionals (dermatologists, nurses, psychologists, dieticians) have been involved. TPE performed by trained dermatology nurses are highly efficient and improve various health-related outcomes. The aim of this position paper is to analyse the aims, modalities and efficacy of TPE in AD, to identify specific roles of dermatology nurses, to assess qualification requirements, and to propose practical recommendations. Potential activities of nurses in ongoing and future TPE programmes for AD patients will be discussed.
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas
J.J. Grob,C. Gaudy-Marqueste,A. Guminski,J. Malvehy,N. Basset-seguin,B. Bertrand,P. Fernandez-Penas,R. Kaufmann,I. Zalaudek,M.C. Fargnoli,L. Tagliaferri,B. Fertil,V. Del Marmol,A. Stratigos,C. Garbe,K. Peris
doi : 10.1111/jdv.17467
Volume 35, Issue 11 p. 2149-2153
No simple staging system has emerged for basal cell carcinomas (BCCs), since they do not follow the TNM process, and practitioners failed to agree on simple clinical or pathological criteria as a basis for a classification. Operational classification of BCCs is required for decision-making, trials and guidelines. Unsupervised clustering of real cases of difficult-to-treat BCCs (DTT-BCCs; part 1) has demonstrated that experts could blindly agree on a five groups classification of DTT-BCCs based on five patterns of clinical situations.
The effectiveness of educational programmes in promoting sun protection among children under the age of 18: a systematic review and meta-analysis
W.M.B. Sim,M.X. Zeng,A. Rojas-Garcia
doi : 10.1111/jdv.17599
Volume 35, Issue 11 p. 2154-2165
Childhood ultraviolet radiation exposure has a strong connection to the development of skin cancer in later life. Therefore, there have been numerous sun protection educational programmes targeted to this age group. However, the association between these have not been well established. This systematic review aims to summarize the evidence on, and assess, the effectiveness of educational programmes in improving sun protection among children under age-18. The protocol was prospectively registered in the PROSPERO database (CRD42020178264). Per PRISMA guidelines, bibliographic databases CENTRAL, OVID (EMBASE, MEDLINE, PsycINFO), LILACS, trial registries, grey literature and other sources were systematically searched for randomized controlled and clinical controlled trials published between database inception to 9 June 2020. Dual independent review of abstracts and full texts was performed. Eligible studies were assessed for methodological quality using the Cochrane risk-of-bias tool. The primary outcome was postintervention scores [standardized mean difference (SMD)] for sun protection (i) knowledge (ii) attitudes and beliefs (iii) behavioural intentions and behaviours. Sidik-Jonkman random effects meta-analysis, sensitivity and subgroup analyses were performed for specific outcomes (sunscreen and sun-safe hat use) which were sufficiently reported. 1350 publications were identified and 24 eligible trials, conducted across 8 different countries, with sufficient aggregate data were included. Small-to-moderate effects of educational programmes were observed across all sun protection outcomes of interest, but negligible effect sizes were demonstrated when specific outcomes were meta-analysed – sunscreen use, SMD 0.18 (95% CI 0.07–0.29; n = 8) and sun-safe hat use, SMD 0.08 (95% CI, 0.00–0.16; n = 6). A promising approach in the future may be to consider targeting children in secondary education with a digitally delivered interactive intervention. Current evidence, however, is insufficient to assess the effects of potential moderators and change in sun protection outcomes is likely not one-size-fits-all. Further research is warranted to direct intervention design and public policy.
Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases – a systematic review
C.C. von Stülpnagel,M. Augustin,L. Düpmann,N. da Silva,R. Sommer
doi : 10.1111/jdv.17348
Volume 35, Issue 11 p. 2166-2184
Patients with chronic skin diseases suffer from physical and psychosocial impairments which can lead to a cumulative life-long burden. Therefore, the concept of cumulative life course impairment (CLCI) was introduced, referring to the non-reversible damage due to the persistent life-long burden. This systematic review (PROSPERO registry number: CRD42020179141) aimed at mapping the risk factors and the associated burden over time in patients with psoriasis, atopic dermatitis (AD) and hidradenitis suppurativa (HS). Three electronic databases were searched (date of the last search: December 2019). Studies with a longitudinal study design that assessed the association between a risk factor and the associated burden over time in patients with psoriasis, AD and HS were included. Quality assessment of the included studies was done using Critical Appraisal Skills Programme (CASP) checklists. In total, 40 publications reflecting 25 different studies were included: nine studies addressed patients with psoriasis, 13 patients with AD, two studies included patients with HS and one study enrolled patients with psoriasis and AD, respectively. Twenty-two potential risk factors with underlying evidence were found in this review. These risk factors include mainly sociodemographic (such as age or gender) and clinical (such as disease severity or comorbidities) variables. Disease severity and comorbidities were the most often studied risk factors, while only a few studies evaluated psychosocial risk factors over time. Patients with chronic skin diseases are at high risk to develop a life-long negative impact from the disease. However, there is a lack of data that evaluates the psychosocial burden and its influence on the patients’ life course over time. The risk factors found in this review help to identify patients at risk, to treat them adequately and, ultimately, to prevent CLCI. These results can be the basis to develop a highly needed tool to assess the risk for CLCI in the future.
Systematic review of single and combined treatments for different types of striae: a comparison of striae treatments
F. Seirafianpour,S. Sodagar,S. Mozafarpoor,H.R. Baradaran,P. Panahi,B. Hassanlouei,A. Goodarzi
doi : 10.1111/jdv.17374
Volume 35, Issue 11 p. 2185-2198
Striae distensae (SD) or stretch marks are among the most common forms of atrophic scarring and cosmetic problems, especially in women, that negatively affect quality of life. The main causes of SD vary widely, but the most significant ones include obesity, pregnancy, high corticosteroid levels, weight changes, endocrine disorders and genetic predispositions. Various modalities are available for the treatment of SD; however, there is still no gold standard therapy for this condition. Given the many questions concerning the preferred therapeutic modalities for SD or their overall cost-effectiveness, this comprehensive systematic review discusses the most prevalent, recent and promising therapies for SD in three main categories, including single therapy, therapeutic comparisons and combination therapy. A systematic search was carried out in Medline, Scopus, Web of Science and Google Scholar for original articles published on the treatment of SD by 20 May 2019. One hundred articles were reviewed and divided into three categories. In the single therapy category, we found that laser and other light-based devices and topical treatments are the most commonly applied interventions. In the therapeutic comparison category, we found that most of the common therapeutic modalities are equally effective and there is no significant difference between them in side-effects and treatment duration. In the combination therapy category, we found that the combination of two or more modalities is usually better than using each one alone.
Tinea capitis asymptomatic carriers: what is the evidence behind treatment?
A. Aharaz,G.B.E. Jemec,R.J. Hay,D.M.L. Saunte
doi : 10.1111/jdv.17462
Volume 35, Issue 11 p. 2199-2207
Tinea capitis is a fungal infection mostly affecting children. Epidemiology is changing over time due to migration, and it has been estimated that up to 40% of children from certain developing countries are affected. The mechanism of transmission is still unclear although asymptomatic carriage seems to have an influence in establishing persistent reservoirs that can cause or fuel epidemics. Screening and prophylactic treatment of close contacts of tinea capitis patients are therefore recommended by several international guidelines, but vaguely and not consistent. The treatments involved can be expensive, hard to integrate in everyday life, have well-known side effects and some are not approved for the treatment of children. The aim of this review was to clarify the evidence behind treatment of human asymptomatic carriers of tinea capitis. Databases were searched for the ‘tinea capitis’, ‘carriers’ and ‘treatment’. Inclusion criteria were clinical trials, observational and interventional studies including case series (10+ cases) and case reports in English, Danish, Swedish, Norwegian and French. Reviews, guidelines, unclear reports and in vitro trials were excluded. A systematic review identified 10 studies with low to moderate evidence levels. The topical treatments ketoconazole, povidone-iodine, miconazole and the systemic antifungals terbinafine and itraconazole have all shown significant effects in the mycological eradication of fungal conidia. General prophylactic hygienic measures may have a benefit. The scientific evidence behind the treatment of asymptomatic carriage of scalp dermatophytes is sparse and not of high quality. Yet, both topical and systemic antifungal agents show treatment efficacy. Considering the possible adverse effects, topical agents are preferable, but with necessary attention to the compliance of asymptomatic contacts with treatment.
Electrochemotherapy with bleomycin for basal cell carcinomas: a systematic review
K. Hendel,G. B. E. Jemec,M. Haedersdal,S. R. Wiegell
doi : 10.1111/jdv.17492
Volume 35, Issue 11 p. 2208-2215
Basal cell carcinoma (BCC) is the most common type of cancer and an increasing incidence stimulates the interest in new treatments such as electrochemotherapy (ECT) with bleomycin. This systematic review focuses on literature from the MEDLINE, Embase, Web of Science, and Cochrane databases. Bleomycin-ECT studies (n = 32) were sorted by the level of evidence adjusted for their BCC data only. The studies included a single randomised controlled trial (RCT), 15 uncontrolled clinical trials, three registry studies, six prospective case series and seven retrospective case series. A Cochrane risk-of-bias assessment of the RCT identified some minor concerns but no predicted risk of bias. The studies were also grouped by bleomycin administration routes: intravenous (n = 14), intralesional (n = 9) and mixed reporting/usage (n = 9). A meta-analysis was not conducted due to the lack of RCTs and the heterogeneity of the included studies. The results of the RCT generally reflected the findings of the other included studies and showed a 92% complete response in 65 bleomycin-ECT–treated BCCs after 2 months, improving to 100% after re-treatment, with a low risk of recurrence. Based on the RCT results and overall data, future studies on BCC treatment with bleomycin-ECT should include large RCTs that compare bleomycin-ECT with standard of care, cost analyses, and clinical feasibility.
Ageing research: rethinking primary prevention of skin cancer
C. Posch
doi : 10.1111/jdv.17660
Volume 35, Issue 11 p. 2216-2218
Concordance between a Mohs surgeon and a dermatopathologist in evaluating Mohs cryosections
S. Atilla,Ö. Gököz,S. Özer,G. Elçin
doi : 10.1111/jdv.17574
Volume 35, Issue 11 p. 2219-2224
Mohs micrographic surgery is the gold standard treatment for high-risk non-melanoma skin cancers. The success of Mohs relies on accurate histopathologic evaluation. Due to law restrictions in some European countries, Mohs surgeons are not permitted to report on histopathology; therefore, a pathologist evaluates the frozen sections.
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial
R.A. Cowan,J.J. Scarisbrick,P.L. Zinzani,J.P. Nicolay,L. Sokol,L. Pinter-Brown,P. Quaglino,L. Iversen,R. Dummer,A. Musiek,F. Foss,T. Ito,J-P. Rosen,M.C. Medley
doi : 10.1111/jdv.17523
Volume 35, Issue 11 p. 2225-2238
Mogamulizumab was compared with vorinostat in the phase 3 MAVORIC trial (NCT01728805) in 372 patients with relapsed/refractory mycosis fungoides (MF) or Sézary syndrome (SS) who had failed ?1 prior systemic therapy. Mogamulizumab significantly prolonged progression-free survival (PFS), with a superior objective response rate (ORR) vs. vorinostat.
The golden ages of inflammatory skin diseases: skyrocketing developments in the therapy of psoriasis and atopic dermatitis
L. Kemény
doi : 10.1111/jdv.17655
Volume 35, Issue 11 p. 2239-2240
Secukinumab effects on disease burden, patient needs and benefits, and treatment satisfaction in patients with plaque psoriasis across European regions: patient perspective data from the PROSE study
N. da Silva,R. Sommer,C.-E. Ortmann,P. Jagiello,T. Bachhuber,M. Augustin
doi : 10.1111/jdv.17525
Volume 35, Issue 11 p. 2241-2249
Cross-cultural differences in healthcare policies and patient–physician communication may influence the quality of care and patients' perceived benefits and satisfaction with psoriasis treatment.
The use of psoriasis biomarkers, including trajectory of clinical response, to predict clearance and remission duration to UVB phototherapy
N. Watson,N. Wilson,F. Shmarov,P. Zuliani,N.J. Reynolds,S.C. Weatherhead
doi : 10.1111/jdv.17519
Volume 35, Issue 11 p. 2250-2258
Remission duration and treatment response following phototherapy for psoriasis are highly variable and factors influencing these are poorly understood.
Chronic urticaria – From ‘Cinderella’ to a ‘Rock star’ in 30 years
M. Gonçalo
doi : 10.1111/jdv.17659
Volume 35, Issue 11 p. 2259-2260
Pruritus and prurigo: a significant advancement on diagnosis, classification, pathogenesis and treatment
A. Reich
doi : 10.1111/jdv.17664
Volume 35, Issue 11 p. 2261-2262
Characteristics of children and adolescents with atopic dermatitis who attended therapeutic patient education
S. Barbarot,F. Boralevi,J. Shourick,F. Sampogna,E. Mahé,S. Merhand,A.-C. Bursztejn,S. Mallet,K. Ezzedine,C. Abasq,C. Taïeb,A. Lasek,C. Bodemer
doi : 10.1111/jdv.17526
Volume 35, Issue 11 p. 2263-2269
Atopic dermatitis (AD) is a chronic, relapsing, inflammatory skin disease. Therapeutic patient education (TPE) has been demonstrated to be effective in AD in reducing disease severity and improving coping and quality of life.
Prevalence, incidence and presence of comorbidities in patients with prurigo and pruritus in Germany: A population-based claims data analysis
M. Augustin,C. Garbe,K. Hagenström,J. Petersen,M.P. Pereira,S. Ständer
doi : 10.1111/jdv.17485
Volume 35, Issue 11 p. 2270-2276
There are currently no published population-based data on prurigo and pruritus epidemiology in Germany.
Improvement in Hidradenitis Suppurativa and quality of life in patients treated with adalimumab: Real-world results from the HARMONY Study
A. Hafner,P.D. Ghislain,R. Kovács,R. Batchelor,A.C. Katoulis,B. Kirby,H. Banayan,M. Schonbrun
doi : 10.1111/jdv.17551
Volume 35, Issue 11 p. 2277-2284
Hidradenitis suppurativa (HS), a chronic, recurrent, debilitating skin disease, is characterized by painful, inflammatory, subcutaneous lesions of the axilla, inguinal and anogenital regions. Overall prevalence of HS is ˜1%, and the impact of disease on patient quality of life (QoL) and healthcare resource utilization (HRU) is high.
Sexually transmitted infections – 30 years later
G.-S. Tiplica
doi : 10.1111/jdv.17667
Volume 35, Issue 11 p. 2285-2286
High prevalence of syphilis in women, minors and precarious patients: a cross-sectional study in a Reunion Island sexually transmitted infection clinic, 2017–2020
A. Delfosse,N. Bouscaren,N. Dupin,J. Jaubert,P.L. Tran,C. Saint Pastou,R. Manaquin,P. Poubeau,P. Gerardin,A. Bertolotti
doi : 10.1111/jdv.17572
Volume 35, Issue 11 p. 2287-2292
Syphilis is a sexually transmitted infection (STI) with a global prevalence estimated at 0.5% in 2012. Syphilis has been on the rise among men who have sex with men (MSM) in high-income countries and remains at endemic levels in low- and middle-income countries. This trend, however, has not been observed in Reunion Island.
High rate of self-improving phenotypes in children with non-syndromic congenital ichthyosis: case series from south-western Germany
L. Frommherz,A. Krause,J. Kopp,A. Hotz,S. Hübner,A. Reimer-Taschenbrecker,F. Casetti,B. Zirn,J. Fischer,C. Has
doi : 10.1111/jdv.17524
Volume 35, Issue 11 p. 2293-2299
Non-syndromic congenital ichthyosis describes a heterogeneous group of hereditary skin disorders associated with erythroderma and scaling at birth. Although both severe and mild courses are known, the prediction of the natural history in clinical practice may be challenging.
An innovative application of follicular unit extraction technique in the treatment of bromhidrosis
H. Li,X. Zhang,W. Wei,L. Zhang,Z. Chen,M. Cao,J. Cheng,L. Du,J. Zhao,Z. Fang,X. Li,P. Chen
doi : 10.1111/jdv.17571
Volume 35, Issue 11 p. 2300-2304
Surgery is the most effective way to treat bromhidrosis, but postoperative complications are still the biggest obstacles for patients to choose surgical treatment.
Vitiligo: 30 years to put together the puzzle pieces and to give rise to a new era of therapeutic options
T. Passeron
doi : 10.1111/jdv.17652
Volume 35, Issue 11 p. 2305-2307
Raman spectroscopy reveals collagen and phospholipids as major components of hyalinosis in the arteriolosclerotic ulcer of Martorell
J. Deinsberger,M. Felhofer,J.P. Kläger,P. Petzelbauer,N. Gierlinger,B. Weber
doi : 10.1111/jdv.17573
Volume 35, Issue 11 p. 2308-2316
Arteriolosclerotic ulcers of Martorell are histologically characterized by hyaline arteriolosclerosis resulting in concentric occlusion of the arteriolar lumina. Although several authors have previously reported on hyaline changes in hypertensive arteriolopathies, so far, little information is available on the molecular composition of hyaline wall depositions.
Fluorescence advanced videodermoscopy: a new method of hairs and scalp evaluation. Comparison with trichoscopy.
A. Rossi,F. Magri,G. Caro,S. Michelini,M. Di Fraia,M.C. Fortuna,G. Pellacani,M. Carlesimo
doi : 10.1111/jdv.17558
Volume 35, Issue 11 p. 2317-2323
Non-invasive diagnostic methods in clinical dermatology are widely used to reduce the need for invasive techniques, with great advantages in terms of cost and time. Dermoscopy is the reference test for the in vivo diagnosis of cutaneous lesions, and when it is performed on the scalp region it is named trichoscopy. Fluorescence advanced videodermoscopy (FAV) has been lately proposed as a new non-invasive method for the in vivo skin examination at high magnification, with cell-level resolution. So far, it has shown promising results for the assessment of melanocytic and vascular lesions and for the in vivo diagnosis of parasitosis.
Development and validation of the Physician's Global Assessment of Fingernail Psoriasis
S. Hudgens,P. Rich,Z. Geng,D. Williams,A. Fleischer,A. Ganguli
doi : 10.1111/jdv.17387
Volume 35, Issue 11 p. 2324-2330
Several clinician-rated scoring systems are available to assess nail psoriasis severity, but only one has been partially validated.
A review of nail findings associated with COVID-19 infection
E. Hadeler,B.W. Morrison,A. Tosti
doi : 10.1111/jdv.17448
Volume 35, Issue 11 p. e699-e709
Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials
D. Thaçi,D. Jullien,A. Egeberg,J.M. Carrascosa,J.J. Wu,I. Pau-Charles,P. Gisondi
doi : 10.1111/jdv.17427
Volume 35, Issue 11 p. e709-e711
Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’?
J.E. Kim,H. Lee,S.S. Paik,J.-Y. Moon,H.J. Yoon,S.-H. Kim
doi : 10.1111/jdv.17476
Volume 35, Issue 11 p. e711-e714
Impact of the COVID-19 pandemic on melanoma diagnosis
P. Gisondi,S. Cazzaniga,S. Di Leo,S. Piaserico,F. Bellinato,M. Pizzolato,A. Gatti,A. Eccher,M. Brunelli,D. Saraggi,G. Girolomoni,L. Naldi
doi : 10.1111/jdv.17493
Volume 35, Issue 11 p. e714-e715
Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine
A.C. Leasure,S.E. Cowper,J. McNiff,J.M. Cohen
doi : 10.1111/jdv.17494
Volume 35, Issue 11 p. e716-e717
Erythema multiforme after CoronaVac vaccination
N.T. Lopes,C.E.O. Pinilla,A.C. Gerbase
doi : 10.1111/jdv.17495
Volume 35, Issue 11 p. e717-e719
Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine
D. Falkenhain-López,C. Gutiérrez-Collar,J. Arroyo-Andrés,I. Gallego-Gutiérrez,J.L. Rodríguez-Peralto,A. Sánchez-Velázquez
doi : 10.1111/jdv.17497
Volume 35, Issue 11 p. e719-e721
Pityriasis rosea developing after COVID-19 vaccination
O.Y. Marcantonio-Santa Cruz,A. Vidal-Navarro,D. Pesqué,A.M. Giménez-Arnau,R.M. Pujol,G. Martin-Ezquerra
doi : 10.1111/jdv.17498
Volume 35, Issue 11 p. e721-e722
Development of eruptive pseudoangiomatosis following COVID-19 immunization – Apropos of 5 cases
A. Mohta,S. K. Jain,R. D. Mehta,A. Arora
doi : 10.1111/jdv.17499
Volume 35, Issue 11 p. e722-e725
Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine
N. Cameli,M. Silvestri,M. Mariano,S.P. Nisticò,A. Cristaudo
doi : 10.1111/jdv.17500
Volume 35, Issue 11 p. e725-e727
New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination
L. Quattrini,L. Verardi,G. Caldarola,G. Peluso,C. De Simone,M. D’Agostino
doi : 10.1111/jdv.17502
Volume 35, Issue 11 p. e727-e729
New-onset cutaneous lichen planus triggered by COVID-19 vaccination
R. Merhy,A.-S. Sarkis,J. Kaikati,L. El Khoury,S. Ghosn,F. Stephan
doi : 10.1111/jdv.17504
Volume 35, Issue 11 p. e729-e730
‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccine
W. Kempf,N. Kettelhack,F. Kind,S. Courvoisier,J. Galambos,K. Pfaltz
doi : 10.1111/jdv.17506
Volume 35, Issue 11 p. e730-e732
Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination
A. Kreuter,S.-N. Burmann,B. Burkert,F. Oellig,A.-L. Michalowitz
doi : 10.1111/jdv.17514
Volume 35, Issue 11 p. e733-e735
Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study
E. Koch,F. Villanueva,M.A. Marchetti,Á. Abarzúa-Araya,C. Cárdenas,J.C. Castro,F. Dominguez,K. Droppelmann,N. Droppelmann,H. Galindo,A. León,J. Madrid,M. Molgó,S. Mondaca,P.H. Montero,P. Uribe,M.A. Villaseca,E. Vinés,C. Navarrete-Dechent
doi : 10.1111/jdv.17522
Volume 35, Issue 11 p. e735-e737
A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine
R. Pasternack,S. Pohjavaara
doi : 10.1111/jdv.17543
Volume 35, Issue 11 p. e737-e738
Dermatoses caused by face mask wearing during the COVID-19 pandemic
O.Yu. Olisova,N.P. Teplyuk,E.V. Grekova,A.A. Lepekhova
doi : 10.1111/jdv.17546
Volume 35, Issue 11 p. e738-e741
Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2
L. Guzmán-Pérez,M. Puerta-Peña,D. Falkenhain-López,J. Montero-Menárguez,C. Gutiérrez-Collar,J.L. Rodríguez-Peralto,J. Sanz-Bueno
doi : 10.1111/jdv.17547
Volume 35, Issue 11 p. e741-e743
Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine
A. Smola,S. Samadzadeh,L. Müller,O. Adams,B. Homey,P. Albrecht,S. Meller
doi : 10.1111/jdv.17549
Volume 35, Issue 11 p. e743-e745
Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccine
F. Nastro,G. Fabbrocini,F. di Vico,C. Marasca
doi : 10.1111/jdv.17550
Volume 35, Issue 11 p. e745-e747
New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three cases
D. Revilla-Nebreda,M. Roncero-Riesco,Á. Santos-Briz,M. Medina-Migueláñez,N. Segurado-Tostón,C. Román-Curto
doi : 10.1111/jdv.17553
Volume 35, Issue 11 p. e747-e749
Herpes Zoster following SARS-CoV-2 vaccination – a series of four cases
M. Alpalhão,P. Filipe
doi : 10.1111/jdv.17555
Volume 35, Issue 11 p. e750-e752
New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report
M. Lehmann,P. Schorno,R.E. Hunger,K. Heidemeyer,L. Feldmeyer,N. Yawalkar
doi : 10.1111/jdv.17561
Volume 35, Issue 11 p. e752-e755
Health-related quality of life in paediatric patients with vitiligo: a systematic review and meta-analysis
J. Nathalie,J. Chang,K. Ezzedine,M. Rodrigues
doi : 10.1111/jdv.17382
Volume 35, Issue 11 p. e755-e756
Mucocutaneous leishmaniasis complicating systemic lupus erythematosus and responding to high dose amphotericin B
A.L. Matos,C. Figueiredo,F. Alves,N. Pereira,M. Gonçalo
doi : 10.1111/jdv.17423
Volume 35, Issue 11 p. e756-e758
Lupus erythematosus tumidus in a patient with mycosis fungoides stage IB after complete response to PUVA
P.A. Vieyra-Garcia,L. Cerroni,R.A. Clark,P. Wolf
doi : 10.1111/jdv.17425
Volume 35, Issue 11 p. e758-e760
A blinking knee: Quincke’s sign as a reaction to insect bite in a chronic lymphocytic leukaemia patient
E. Robustelli Test,E. Moggio,P. Sena,D.M. Gambini
doi : 10.1111/jdv.17426
Volume 35, Issue 11 p. e761-e762
The spectrum of morphologic patterns of nodular melanoma: a study of the International Dermoscopy Society
A. Niforou,D. Sgouros,A. Lallas,A. Zaras,A. Scope,H. Tsao,G. Argenziano,C. Longo,H. Kittler,A. Stratigos,IDS Thin NM Project Investigators
doi : 10.1111/jdv.17428
Volume 35, Issue 11 p. e762-e765
Use of self-applied sculptured gel nails may increase the risk of allergy to (meth)acrylates in children and adolescents
M. Tramontana,K. Hansel,L. Bianchi,R. Marietti,L. Stingeni
doi : 10.1111/jdv.17429
Volume 35, Issue 11 p. e765-e767
HAc40 is a novel microbiome modulator, effective on atopic dermatitis in children: data from two pilot vehicle-controlled trials
R. Sacchetti,G. Gregori,E. Moggio,L. Gobbo,L. Bonzano,G. Pellacani
doi : 10.1111/jdv.17431
Volume 35, Issue 11 p. e767-e768
A study of corticophobia in adult psoriasis patients: a French cross-sectional observational study
E. Moreau,H. Rousseau,A. Marzouki Zerouali,E. Melgar,J. Henry,J.L. Schmutz,G.F. Escobar,A.C. Bursztejn
doi : 10.1111/jdv.17435
Volume 35, Issue 11 p. e768-e770
Aicardi–Goutières syndrome: a possible explanation of angiokeratoma of Mibelli
E. Cinotti,M. Bertello,C. Habougit,F. Rongioletti,F. Cambazard,J.C. Antoine,L. Tognetti,P. Rubegni,J.L. Perrot
doi : 10.1111/jdv.17440
Volume 35, Issue 11 p. e770-e772
Mobile health skin cancer risk assessment campaign using artificial intelligence on a population-wide scale: a retrospective cohort analysis
T.E. Sangers,T. Nijsten,M. Wakkee
doi : 10.1111/jdv.17442
Volume 35, Issue 11 p. e772-e774
Two cases of quinine-induced fixed ‘drug’ eruption induced by long drinks
A.S. Bohne,C. Dietrich,K. Morrison,T. Schwarz,U. Wehkamp,M. Kaeding
doi : 10.1111/jdv.17453
Volume 35, Issue 11 p. e774-e776
Diagnostic and management challenges of erosive pustular dermatosis of the scalp: a retrospective study in Greek population
S. Siskou,A. Lallas,K. Theodoropoulos,D. Sgouros,M. Trakatelli,A. Patsatsi,A. Trigoni,M. Manoli,C. Papageorgiou,K. Liopyris,A. Katoulis,A. Stratigos,D. Ioannides,E. Lazaridou,Z. Apalla
doi : 10.1111/jdv.17455
Volume 35, Issue 11 p. e776-e779
Work-related hazards due to oak processionary moths: a pilot survey on medical symptoms
S. Forkel,J. Mörlein,M. Sulk,C. Beutner,W. Rohe,M.P. Schön,J. Geier,T. Buhl
doi : 10.1111/jdv.17456
Volume 35, Issue 11 p. e779-e782
New compound heterozygous SPINK5 mutations in a Chinese infant with Netherton syndrome
Q. Wang,F. Qiu,H. Wu,Y.-M. Fan
doi : 10.1111/jdv.17457
Volume 35, Issue 11 p. e782-e784
Facial seborrheic keratosis with unusual dermoscopic patterns can be differentiated from other skin malignancies by in vivo reflectance confocal microscopy
F. Farnetani,G. Pedroni,N. Lippolis,M. Giovani,S. Ciardo,J. Chester,S. Kaleci,C. Pezzini,C. Cantisani,A. Dattola,M. Manfredini,E. Dika,A. Patrizi,G. Pellacani
doi : 10.1111/jdv.17470
Volume 35, Issue 11 p. e784-e787
Prevalence of adult atopic dermatitis in the general population, with a focus on moderate-to-severe disease: results from the Lifelines Cohort Study
J. Zhang,L. Loman,A.N. Voorberg,M.L.A. Schuttelaar
doi : 10.1111/jdv.17471
Volume 35, Issue 11 p. e787-e790
Hair flag sign: Macroscopic and trichoscopic feature of hair regrowth in alopecia areata
L.T. Fernández,D.E. Kubelis-López,F.Z. Muñoz-Garza,J. Ocampo-Candiani,E.L. Alba-Rojas
doi : 10.1111/jdv.17473
Volume 35, Issue 11 p. e790-e792
Erythema punctatum Higuchi: reconsidering its relationship with adrenergic urticaria and eruptive pseudoangiomatosis
A. Mori,Y. Kaku,T. Dainichi
doi : 10.1111/jdv.17474
Volume 35, Issue 11 p. e792-e793
Psoriasis vs. its mimickers: when the dermatoscope casts light on challenging cases in everyday clinical practice
I. Papadimitriou,K. Bakirtzi,A. Lallas,E. Vakirlis,E. Sotiriou,E. Lazaridou,D. Ioannides
doi : 10.1111/jdv.17475
Volume 35, Issue 11 p. e793-e796
Successful treatment with narrowband ultraviolet B phototherapy in prurigo pigmentosa
M.S. Jang,K.S. Suh,D.I. Kwon,J.H. Jung,S.H. Seong,K.H. Lee,J.H. Kang,J.B. Park
doi : 10.1111/jdv.17477
Volume 35, Issue 11 p. e796-e798
Meek micrografting: a novel surgical technique for the treatment of depigmentation
V.S. Narayan,N.F. Post,P.P.M. Van Zuijlen,M.W. Bekkenk,A. Wolkerstorfer
doi : 10.1111/jdv.17478
Volume 35, Issue 11 p. e798-e801
Atrichia with papular lesions: a differential diagnosis of alopecia universalis not to be missed
A. Ibrahim,F. Buket Basmanav,G. Bohelay,A. Lévy,R.C. Betz,F. Caux
doi : 10.1111/jdv.17479
Volume 35, Issue 11 p. e801-e803
Two cases of unique presentation of anaphylaxis to Japanese butterbur scapes and literature review
M. Onaka,H. Mitsui,A. Honobe-Tabuchi,N. Deguchi,Y. Ogawa,S. Shimada,T. Kawamura
doi : 10.1111/jdv.17481
Volume 35, Issue 11 p. e803-e804
Genetic polymorphisms in immunity related genes and the vitamin D receptor gene and risk of cutaneous T-cell lymphoma in Greek population
A. Velissari,E. Lakiotaki,V. Nikolaou,K.V. Argyropoulos,A. Stratigos,G. Daikos,K. Konstantopoulos,M. Siakantaris
doi : 10.1111/jdv.17482
Volume 35, Issue 11 p. e805-e807
Human papillomavirus type 67 in cutaneous squamous cell dysplasia and carcinoma
A. Kreuter,S. Silling,A. Potthoff,F. Oellig,A.L. Michalowitz,U. Wieland
doi : 10.1111/jdv.17496
Volume 35, Issue 11 p. e807-e809
The art of observation: visual literacy for dermatologists
R. Matthews,A. Wray,S. Walsh,C.E.M. Griffiths,H.S. Young
doi : 10.1111/jdv.17501
Volume 35, Issue 11 p. e809-e811
Temperature-controlled laminar airflow in adult atopic dermatitis patients – an observational study
S. Traidl,L.M. Roesner,P. Kienlin,G. Begemann,A. Schreiber,T. Werfel,A. Heratizadeh
doi : 10.1111/jdv.17507
Volume 35, Issue 11 p. e812-e815
National trends in psoriasis readmissions: a longitudinal study of the nationwide readmission database from 2010 to 2018
E. Edigin,M.M. Rivera Pavon,P.O. Eseaton,C. Hernandez,A. Manadan
doi : 10.1111/jdv.17508
Volume 35, Issue 11 p. e815-e817
Lichen sclerosus et atrophicus on dimples: a striking example of immunocompromised cutaneous district
O. Ozbagcivan,D.F. Ayozcan,B. Lebe
doi : 10.1111/jdv.17509
Volume 35, Issue 11 p. e817-e819
The right default mode network is associated with the severity of chronic itch
H. Mochizuki,C.D. Kursewicz,J.S. Nomi,G. Yosipovitch
doi : 10.1111/jdv.17510
Volume 35, Issue 11 p. e819-e821
A case of delayed antihistamine cutaneous drug eruption and piperidine derivative cross-reaction
M. Lagassy,M. Aroux-Pavard,P. Joly,F. Tetart,O. Bauvin
doi : 10.1111/jdv.17511
Volume 35, Issue 11 p. e821-e823
A rare case of neuro- and otosyphilis in secondary syphilis
S. Traidl,Y. Angela,A. Stender,A. Kulberg,M. Tronnier,N.K. Prenzler,M.P. Wattjes,A. Kapp,M. Stangel,V. Schacht,T. Werfel
doi : 10.1111/jdv.17512
Volume 35, Issue 11 p. e823-e826
Exploring the association between lichen planopilaris, cardiovascular and metabolic disorders
R.R.Z. Conic,J. Maghfour,G. Damiani,W. Bergfeld
doi : 10.1111/jdv.17513
Volume 35, Issue 11 p. e826-e828
An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis treated with ixekizumab from 16 clinical studies
A. Blauvelt,M. Ramharter,A.D. Cohen,W. Xu,H. Patel,C. Schuster,E. Riedl,L. Puig
doi : 10.1111/jdv.17554
Volume 35, Issue 11 p. e828-e831
